Cannara Biotech Inc. LOVFF
Set alert
1.43 USD 0.00 0.00%
At close · Oct 29
1.41 Day range 1.41
1.12 52-week range 1.55
- YTD
- +12.44%
- 1 year
- +19.00%
- Open
- 1.41
- Prev close
- 1.43
- Mkt cap
- 141.06M
- Vol
- 100
- Avg vol
- 4.84K
- EPS
- 0.08
- P/E
- 17.85
More statistics
- Low
- 1.41
- High
- 1.41
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 2, 2026 | 4 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| RSI: Overbought | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
News
- Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
- Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
- Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange
- Cannara Biotech Inc. (LOVE) Opens the Market
- Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
- 'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
- Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion
- Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
- Cannara Announces Grant of Options and RSUs
- Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
Your note
Sign in to keep a note on LOVFF — it syncs with the Stock Master app.